Abstract

Vedant S. Patil, Yash A. Patil, Dr. Prashant S. Malpure*, Dr. Khanderao R. Jadhav and Dr. Rishikesh S. Bachhav

ABSTRACT

Schizophrenia could be a long-term and severe disturbance characterised by abnormalities in thinking, perception, emotions, language, sense of self, and behaviour. This report presents the Clinical pharmacists' role within the management of a patient diagnosed with schizophrenia with symptoms of psychosis. A 20-year-old African male adult who was rumoured to be wandering around the city from one bank to another was in remission. The patient was admitted to a hospital's medical speciality unit and diagnosed with schizophrenia. Key interventions offered enclosed speedy tranquilization, electroshock, and psychotherapy. On admission, the patient was given IV benzodiazepine, IM major tranquillizer, IV club drug, IM flupentixol, olanzapine tablets, and trihexyphenidyl tablets. Problems raised by clinical pharmacists throughout the patient's admission included a lack of various medication for rapid tranquilization, a lack of initial investigations and documentation of the patient's vital organ, the initiation of major tranquilliser medical aid without initial observance and screening for abuse, an inappropriate dose at the initiation of major tranquilliser medications, an untreated indication, and the occurrence of incomprehensible doses. Clinical pharmacist interventions aided in the improvement of the patient's symptoms prior to hospital discharge. The case demonstrates the importance of clinical pharmacists being included in the multidisciplinary team during the management of patients with mental illness.